ATXI (OTC)
AVENUE THERAPEUTICS INC
$0.150000
+0.000000 (+0.00%)
Prev close: $0.150000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Alexandra MacLean
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $3.38M
- Employees
- 4
- P/E (TTM)
- —
- P/B (TTM)
- 7.91
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2024 (Q3)
|
$-1.92 | $-0.96 | -0.9612 | -100.25% |
|
Jun 2024 (Q2)
|
$-6.43 | $-1.07 | -5.3590 | -500.37% |
|
Mar 2024 (Q1)
|
$-15.40 | $-9.18 | -6.2200 | -67.76% |
|
Dec 2023 (Q4)
|
$4.50 | $-7.65 | +12.1500 | +158.82% |
Financial Statements
| Research and Development | $1.35M |
| Operating Income/Loss | -$3.93M |
| Income/Loss From Continuing Operations After Tax | -$3.78M |
| Income/Loss From Continuing Operations Before Tax | -$3.78M |
| Net Income/Loss | -$3.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$36.00K |
| Net Income/Loss Attributable To Parent | -$3.74M |
| Net Income/Loss Available To Common Stockholders, Basic | $5.07M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$8.81M |
| Preferred Stock Dividends And Other Adjustments | -$8.81M |
| Basic Earnings Per Share | $0.77 |
| Basic Average Shares | 3,313,491 |
| Assets | $3.73M |
| Current Assets | $3.73M |
| Noncurrent Assets | $0.00 |
| Liabilities | $1.42M |
| Current Liabilities | $1.42M |
| Noncurrent Liabilities | $0.00 |
| Equity | $2.30M |
| Equity Attributable To Noncontrolling Interest | -$1.25M |
| Equity Attributable To Parent | $3.56M |
| Liabilities And Equity | $3.73M |
| Net Cash Flow From Operating Activities | -$1.74M |
| Net Cash Flow From Operating Activities, Continuing | -$1.74M |
| Net Cash Flow From Investing Activities | -$1.11M |
| Net Cash Flow From Investing Activities, Continuing | -$1.11M |
| Net Cash Flow From Financing Activities | $2.86M |
| Net Cash Flow From Financing Activities, Continuing | $2.86M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$3.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.78M |
| Other Comprehensive Income/Loss | $0.00 |